Note for the editors: for the full text of the press release see enclosed pdf or click here>
Financial calendar |
|
4 November 2020 | Virtual Investor Event |
16 February 2021 | Publication of full year 2020 results |
5 May 2021 | Publication of the results of the first three months of 2021 |
6 May 2021 | Annual General Meeting of Shareholders |
3 August 2021 | Publication of the half year results of 2021 |
2 November 2021 | Publication of the results of the first nine months of 2021 |
Additional Information
Today DSM will hold a conference call for media at 08:00 CET and a conference call for investors and analysts at 09:00 CET. Details on how to access these calls can be found on the DSM website, www.dsm.com.
DSM – Bright Science. Brighter Living.™
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at
www.dsm.com.
Find us on:
Facebook
Twitter
LinkedIn
YouTube
Forward Looking Statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
| Contact: |
| Company Name: Royal DSM
Investor Relations, Dave Huizing, t. +31 (0) 45 578 2864, e. Email Contact Media Relations| Lieke de Jong, t. +31 (0) 45 578 2420, e. Email Contact Financial data for Royal DSM |
